Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression

计划入组 21 人 · 首次发布于 2011 年 8 月 9 日

Excitability Protocol: Voltage-gated Ion Channels

计划入组 30 人 · 首次发布于 2022 年 5 月 10 日

The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

计划入组 30 人 · 首次发布于 2025 年 10 月 2 日

voltage-gated sodium channel modulators (Xention)

Nav1.7 subunit sodium channel antagonists (Anabios)

Kv1.3 potassium channel inhibitors (Xention)

Channel Infrastructure NZ Ltd

United Microelectronics

Harbin Medisan Pharmaceutical Co., Ltd .

FDA Accepts Vertex's Suzetrigine NDA with Priority Review for Acute Pain

Vertex's Non-Opioid Suzetrigine Shows Promise in Phase 3 Acute Pain Trials

FDA Gears Up for Critical Decisions on Alzheimer's, Breast Cancer, and Neurological Therapies in Early 2025